J 2019

Clinical and Functional Characterization of a Novel URAT1 Dysfunctional Variant in a Pediatric Patient with Renal Hypouricemia

STIBURKOVA, Blanka, Jana BOHATA, Iveta MINARIKOVA, Andrea MANCIKOVA, Jiri VAVRA et. al.

Základní údaje

Originální název

Clinical and Functional Characterization of a Novel URAT1 Dysfunctional Variant in a Pediatric Patient with Renal Hypouricemia

Autoři

STIBURKOVA, Blanka (203 Česká republika, garant), Jana BOHATA (203 Česká republika), Iveta MINARIKOVA (203 Česká republika), Andrea MANCIKOVA (203 Česká republika), Jiri VAVRA (203 Česká republika), Vladimir KRYLOV (203 Česká republika) a Zdeněk DOLEŽEL (203 Česká republika, domácí)

Vydání

Applied Sciences-Basel, BASEL, MDPI, 2019, 2076-3417

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30217 Urology and nephrology

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 2.474

Kód RIV

RIV/00216224:14110/19:00110982

Organizační jednotka

Lékařská fakulta

UT WoS

000488603600041

Klíčová slova anglicky

SLC22A12; URAT1; hypouricemia; uric acid transporters; excretion fraction of uric acid

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 17. 2. 2020 10:52, Mgr. Tereza Miškechová

Anotace

V originále

Renal hypouricemia (RHUC) is caused by an inherited defect in the main (reabsorptive) renal urate transporters, URAT1 and GLUT9. RHUC is characterized by decreased concentrations of serum uric acid and an increase in its excretion fraction. Patients suffer from hypouricemia, hyperuricosuria, urolithiasis, and even acute kidney injury. We report the clinical, biochemical, and genetic findings of a pediatric patient with hypouricemia. Sequencing analysis of the coding region of SLC22A12 and SLC2A9 and a functional study of a novel RHUC1 variant in the Xenopus expression system were performed. The proband showed persistent hypouricemia (67-70 mu mol/L; ref. range 120-360 mu mol/L) and hyperuricosuria (24-34%; ref. range 7.3 +/- 1.3%). The sequencing analysis identified common non-synonymous allelic variants c.73G > A, c.844G > A, c.1049C > T in the SLC2A9 gene and rare variants c.973C > T, c.1300C > T in the SLC22A12 gene. Functional characterization of the novel RHUC associated c.973C > T (p. R325W) variant showed significantly decreased urate uptake, an irregular URAT1 signal on the plasma membrane, and reduced cytoplasmic staining. RHUC is an underdiagnosed disorder and unexplained hypouricemia warrants detailed metabolic and genetic investigations. A greater awareness of URAT1 and GLUT9 deficiency by primary care physicians, nephrologists, and urologists is crucial for identifying the disorder.